[1]
|
王业明,徐逸天,曹彬. 新型冠状病毒感染传播、发病机制、诊断和治疗的进展[J]. 中华结核和呼吸杂志,2021,44(7):684-688. doi: 10.3760/cma.j.cn112147-20201120-01106
|
[2]
|
Lu R,Zhao X,Li J,et al. Genomic characterisation and epidemiology of 2019 novel coronavirus:Implications for virus origins and receptor binding[J]. Lancet Lond Engl,2020,3959(3):565-574.
|
[3]
|
Chen L,Zhao J,Peng J,et al. Detection of SARS-CoV-2 in saliva and characterization of oral symptoms in COVID-19 patients[J]. Cell Prolif,2020,53(12):12923.
|
[4]
|
Hindson J. COVID-19:Faecal–oral transmission?[J]. Nature Reviews Gastroenterology &Hepatology,2020,17(5):259.
|
[5]
|
To K K,Tsang O T,YipC C,et al. Consistent detection of 2019 novel coronavirus in saliva[J]. Clin Infect Dis,2020,71(5):841-843.
|
[6]
|
Xu H,Zhong L,Deng J,et al. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa[J]. Int J Oral Sci,2020,12(1):8. doi: 10.1038/s41368-020-0074-x
|
[7]
|
Tay M Z,Poh C M,Rea L,et al. The trinity of COVID‐19:immunity,inflammation and intervention[J]. Nat Rev Immunol,2020,20(6):363-374.
|
[8]
|
Sapkota D,Søland T M,Galtung H K,et al. COVID-19 salivary signature:Diagnostic and research opportunities[J]. J Clin Pathol,2020,74(6):344-349.
|
[9]
|
Santos J A,Normando A G C,Carvalho da Silva R L,et al. Oral mucosal lesions ina COVID‐19 patient:New signs or secondary manifestations?[J]. Int J Infect Dis,2020,97(2):326-328.
|
[10]
|
Mullol J,Alobid I,Marino-Sanchez F,et al. The loss of smell and taste in the COVID-19 outbreak:A tale of many countries[J]. Curr Allergy Asthma Rep,2020,20(10):61. doi: 10.1007/s11882-020-00961-1
|
[11]
|
Benazzo M,Cassaniti I,Maiorano E,et al. SARS‐CoV‐2 virologic and immunologic correlates in patients with olfactory and taste disorders[J]. Microorganisms,2020,8(7):1052. doi: 10.3390/microorganisms8071052
|
[12]
|
MarinoSanchez F,SantamariaGadea A,De Los Santos G,et al. Psychophysical olfactory testing in COVID-19:Is smell function really impaired in nearly all patients?[J]. Int Forum Allergy Rhinol,2020,10(8):951-952.
|
[13]
|
Sakaguchi W,Kubota N,Shimizu T,et al. Existence of SARS-CoV-2 entry molecules in the oral cavity[J]. Int J Mol Sci,2020,21(17):6000. doi: 10.3390/ijms21176000
|
[14]
|
Finsterer J,Stollberger C. Causes of hypogeusia/hyposmia in SARS-CoV2 infected patients[J]. J Med Virol,2020,92(12):1793-1794.
|
[15]
|
Jothimani D,Kailasam E,Danielraj S,et al. COVID-19:Poor outcomes in patients with zinc deficiency[J]. Int J Infect Dis,2020,100(3):343-349.
|
[16]
|
Favia G,Tempesta A,Barile G,et al. Covid-19 symptomatic patients with oral lesions:Clinical and histopathological study on 123 cases of the university hospital policlinic of bari with a purpose of a new classification[J]. J Clin Med,2021,10(4):757. doi: 10.3390/jcm10040757
|
[17]
|
Gherlone E F,Polizzi E,Tete G,et al. Frequent and persistent salivary gland ectasia and oral disease after COVID-19[J]. J Dent Res,2021,100(5):464-471. doi: 10.1177/0022034521997112
|
[18]
|
Farshidfar N, Hamedani S. Hyposalivation as a potential risk for SARS-CoV-2 infection: Inhibitory role of saliva[J]. Oral Dis, 2020, 27(Suppl 3): 750-751.
|
[19]
|
Biadsee A,Kassem F,Dagan O,et al. Olfactory and oral manifestations of COVID-19:Sex-related symptoms-A potential pathway to early diagnosis[J]. Otolaryngol Head Neck Surg,2020,163(4):722-728. doi: 10.1177/0194599820934380
|
[20]
|
Hockova B,Riad A,Valky J,et al. Oral Complications of ICU patients with COVID-19:Case-series and review of two hundred tencases[J]. J Clin Med,2021,10(4):581. doi: 10.3390/jcm10040581
|
[21]
|
Iranmanesh B,Khalili M,Amiri R,et al. Oral manifestations of COVID-19 disease:A review article[J]. Dermatol Ther,2021,34(1):14578.
|
[22]
|
Riad A,Gomaa E,Hockova B,et al. Oral candidiasis of COVID-19 patients:Case report and review of evidence[J]. J CosmetDermatol,2021,20(6):1580-1584.
|
[23]
|
Le Balch P,Pinceaux K,Pronier C,et al. Herpes simplex virus and cytomegalovirus reactivations among severe COVID-19 patients[J]. Crit Care,2020,24(1):530. doi: 10.1186/s13054-020-03252-3
|
[24]
|
Burgos Ponce J, Trijoe K C. Overlapping findings or oral manifestations in new SARS- CoV-2 infection[J]. Oral Dis, 2020 , 27 (Suppl 3): 781-782.
|
[25]
|
Patel J, Woolley J. Necrotizing periodontal disease: Oral manifestation of COVID‐19[J]. Oral Dis, 2021, 27 (Suppl 3): 768-769.
|
[26]
|
Anand P S,Jadhav P,Kamath K P,et al. A case-control study on the association between periodontitis and coronavirus disease (COVID-19)[J]. J Periodontol,2021,18(1):1-7.
|
[27]
|
Halepas S,Lee K C,Myers A,et al. Oral manifestations of COVID-2019-related multisystem inflammatory syndrome in children:A review of 47 pediatric patients[J]. J Am Dent Assoc,2021,152(3):202-208. doi: 10.1016/j.adaj.2020.11.014
|